Introduction
Furazolidone or N-(5-nitro-2-furfurylidene)-3-amino-2-oxazolidone, one of the members of the group of synthetic nitrofurans, displays a wide spec trum of antibacterial activity [ 1 -4 ] and has found useful application in human therapy [5] . The mode of action at the m olecular level of this drug has been under active study in our laboratory. The drug at the concentration level o f 0.5 (ig/ml inhibited DNA syn thesis while stim ulating RNA synthesis at the same time and causing filam entation of the cells [6 , 7] , DNA of cholera phage < 2> 149 was at least 10 times sensitive to this inhibitory action o f furazolidone [8 , 9] . In an attem pt to explain the basis of the inhibi tion of DNA biosynthesis it was found that the drug underwent m etabolic activation or transform ation within the cells and then produced interstrand cross links in DNA [10, 11] . The drug has i-ecently been shown to exhibit radiom im etic property [1 2 ].
It was interesting to note that furazolidone ex hibited a different type of interaction with DNA in vitro, an intercalative type of binding leading to ther mal stabilisation of DNA and inhibition of its diges tion by DNase [13] . Such intercalative in vitro bind ing o f the drug to DNA led to the detection of its photobiological activity, a property till then un known in the literature. The drug was found to cause photodynamic inactivation of choleraphages and al so to render protection to the same phages against UV inactivation [14] [15] [16] . Since this in vitro interac tion of furazolidone with DNA might have im por tant practical applications, e.g., in the treatment of surface infection by the so called photochem othera py, further characterization of such in vitro interac tion seems im portant and useful. The present com munication reports in this context, the effect of Cu(II) ions on the therm al stabilisation of furazoli done-DNA complex and indicates that the drug has a preference for A -T base pairs in DNA.
Materials and M ethods
Chemically pure furazolidone was obtained as a gift sample from Smith, Kline and French (India) Ltd., Bombay. The drug concentrations were deter mined spectrophotom etrically using the molar ex tinction coefficient of 16 650 m -1 cm -1 at 367 nm [13] .
Calf thymus DNA (type I) and Micrococcus lysodeikticus DNA were obtained from Sigma Chemical Co., USA and were always tested for their nativeness and purity [11, 13, 17] , Vibrio cholerae DNA and Pseudomonus pyociania DNA used in this study were isolated, purified and characterised in our laborato ry as described elsewhere [13, 17, 18] . DNA concen trations in terms of nucleotide phosphate were deter mined spectrophotom etrically by using molar ex tinction coefficient (fi) at 260 nm for calf thymus DNA (6600 M"1 cm -1), for V. cholerae DNA (6400 M-1 cm "1), for P. pyociania DNA (6700 m _1 cm -1) and for M. lysodeikticus DNA (6900 m _1 cm -1).
All experiments were conducted either in 5 mM NaCl, pH 6 . 8 or in 1 mM tris-HCl buffer, pH 7.4. Glass distilled deionised water and analytical grade reagents were used throughout. Cu(II) ions were used in the form o f C u S 0 4, 5 H 20 . The drug obeyed Beer's law in the concentration range used in this study. Addition o f suitable am ount of Cu(II) ions to DNA or to drug-D N A complex was done following the method described previously [19, 2 0 ].
The thermal strand separation profile o f DN A in the presence or absence of furazolidone or Cu(II) ions or both was determ ined as described previously [11, 17, 21] . The tem perature o f the solution within the reference cell of the spectrophotom eter was measured by a calibrated therm ocouple system. The absorbance readings were corrected for volume ex pansion [22] , The transition tem perature, T m was defined as the tem perature corresponding to which the hyperchromicity, h (AT/A 25) is given by h = V 2 (/imax + 1 ), where hmSLX is the m axim um hyperchro micity.
Results
The transition tem perature of V. cholerae D N A in 5 mM NaCl, pH 6 . 8 was 72 °C (Fig. 1) . W hen 15 |im furazolidone was allowed to complex with DN A (furazolidone/DNA m olar ratio o f 0.25) in the same solvent, the transition tem perature of DNA was en hanced to 79.5 °C (Fig. 1) . The transition was steep er in the presence o f furazolidone and was indicative of its more cooperative nature. Further increase of the drug/D N A m olar ratio did not increase the transition tem perature by any significant degree.
Transition tem perature of V. cholerae D N A (60 (im) was lowered to 65.5 °C in the presence of 15 (jm Cu(II) ions in 5 mM NaCl, pH 6 .8 . Keeping the DNA concentration fixed, its transition tem pera ture was lowered to 46 °C and 33 °C in the presence of 30 jiM and 100 |iM Cu(II) ions respectively ( Fig. 1 ; Table I ). Cu(II) ions o f different concentrations were not equally effective in lowering the transition tem perature of furazolidone-D N A complex. W hen Cu(II) ions of m olarity same as that o f furazolidone was added to furazolidone-D N A complex, the transi tion tem perature was lowered from 79.5 °C to 76 °C (Table I) increasing concentration of Cu(II) ions caused in creased lowering of the transition tem perature of the furazolidone-DNA complex (Table I) , but in all such cases the lowering was not as much as was done by the corresponding amount of Cu(II) ions alone (without furazolidone). For the same value of ligand to DNA ratio and using DNAs of different base composition, the tran sition tem peratures of the furazolidone-DNA com plexes were different. The transition tem perature in crease linearly with the % A -T content of DNAs (Fig. 2 ) . Table I . Thermal melting tem peratures of native D NA and furazolidone-DNA complex in presence of Cu(II) ions in 5 mM NaCl, pH 6 .8 . In all cases the concentrations o f DNA and furazolidone were 60 |iM and 15 hm respectively. 
Concentration of Cu(II) ions

Discussion
The results presented here have confirmed and ex tended our previous findings [13] on the in vitro in teraction of furazolidone with DNA. Furazolidone binding leads to thermal stabilisation of DNA and this has been found true for DNAs of different % A -T content. This study has further confirmed the previous reports on the Cu(II) ions induced lowering of the transition tem perature of DNA [19, 20, [23] [24] [25] [26] . The present observations on the effects of Cu(II) ions on the thermal stabilisation of furazolidone-DNA complex appears to be interesting. Cu(II) ions were not equally effective in lowering the transi tion tem perature of furazolidone-DNA complex. When Cu(Il) ions were added subsequent to the for mation of furazolidone-DNA complex, the transition temperatures of furazolidone-DNA-Cu(II) com plexes were always significantly higher than the cor responding values of DNA -Cu(II) complexes and this was significant even when the molar concentra tion of Cu(II) ions was more than 6 fold higher than that of furazolidone. These data indicated that fu razolidone and Cu(II) ions did not complete for the same sites in DNA. The nature of the interaction of Cu(II) ions with DNA has been investigated by many workers [23] [24] [25] [26] and different interpretations were presented. It is generally believed that at the low ionic strength of the solvent, two different types of interaction between Cu(II) ions and DNA take place simultaneously. Type I interaction has the overall effect of stabilising [24] or at least non denaturing [25] the DNA and is supposed to be pre dom inant at lower values of the Cu(II) ions/D N A ratio. Type II interaction has an overall destabilisa tion effect on DNA and is predom inant at higher values (> 0 .3 ) of Cu(II) ions/D N A ratio [25] . This type II interaction should thus be of great concern in our case where the Cu(II) ions/D N A ratio is greater than 0.25. Although there are differences of opinion in respect of the exact nature of the interaction in volved in the type II reaction, it is generally agreed that the destabilisation of DNA structure is initiated by the breakage of bonds between G -C base pairs [24, 25] . It appears that furazolidone binding has very little to do with the G -C base pairs. This idea was supported by the therm al transition profiles of furazolidone-DNA complexes for DNAs of different G -C or A -T content, which clearly indicated that furazolidone has a preference for A -T base pairs.
In conclusion, this study has thus shown that fu razolidone on complexing with DNA led to its ther mal stabilisation irrespective of its base composition. When equim olar amounts of furazolidone and Cu(II) ions were used, the stabilisation effects of fu razolidone prevailed over the destabilisation effect of Cu(II) ions. The furazolidone-D NA complexing had a preference for A -T base pairs.
